Home | Drugs Approvals and Trials

Drugs Approvals and Trials

Promising new lupus drug being tested at Temple

The drug—anifrolumab—was shown to reduce symptoms in patients in early phases of clinical research. ...

Major advance in designer drug development

In a world-first, researchers from The University of Queensland and University of Washington (UW) have produced tailor-made peptides – an advance expected ...

Atomic-scale MRI holds promise for new drug discovery

Researchers at the University of Melbourne have developed a way to radically miniaturise a Magnetic Resonance Imaging (MRI) machine using atomic-scale quantum computer technology. ... Full story

Single-Arm Trials Improve Early Access to Rare Cancer Drugs

LUGANO-COPENHAGEN – Although randomised clinical trials (RCTs) remain the gold standard for evaluating the benefit/risk of cancer drugs, single-arm trials (SATs) can provide invaluable opportunities ... Full story

New research to offer blueprint for oral drug delivery

Scientists are working to develop a blueprint for a new generation of nanomedicines that could soon make it possible for patients to take medicines such as insulin orally rather than via injections. ... Full story

FDA approves Amjevita, a biosimilar to Humira

The U.S. Food and Drug Administration today approved Amjevita (adalimumab-atto) as a biosimilar to Humira (adalimumab) for multiple inflammatory diseases. ... Full story

To produce biopharmaceuticals on demand, just add water

Freeze-dried cellular components can be rehydrated to churn out useful proteins. ... Full story

Calls for greater transparency in the release of clinical trial data

Researchers have called for greater transparency in the public release of clinical trial data after a study revealed significant under-reporting of side effects in medical treatments. ... Full story

New Big Data Approach Predicts Drug Toxicity in Humans

Researchers can now predict the odds of experimental drugs succeeding in clinical trials, thanks to a new data-driven approach developed by Weill Cornell Medicine scientists. The method detects toxic side effects that may disqualify drugs from human use, giving drug developers an early warning before initiating clinical trials, according to a new study published Sept. 15 in Cell Chemical Biology. ... Full story

Molecular Flexibility Shown to Help Pharmaceutical Drugs Bind to Their Targets

Breakthrough could open up new directon when designing pharmaceutical drugs ... Full story

1 2 3 4 5 6 7 8 9 10 next last total: 575 | displaying: 1 - 10